Performances of Two Rapid LAMP-based Techniques for the Intrapartum Detection of Group B Streptococcus Vaginal Colonization

Overview

Journal Ann Clin Microbiol Antimicrob

Publisher Biomed Central

Specialties Infectious Diseases
Microbiology

Date 2024 Apr 25

PMID 38664821

Authors

Rym Charfi

Cecile Guyonnet

Meiggie Untrau

Gaelle Giacometti

Thierry Paper

Claire Poyart

Celine Plainvert

Asmaa Tazi

Affiliations

Soon will be listed here.

Abstract

Purpose: Group B Streptococcus (GBS) is the leading cause of invasive infections in newborns. The prevention of GBS neonatal disease relies on the administration of an intrapartum antibiotic prophylaxis to GBS-colonized women. In recent years, rapid intrapartum detection of GBS vaginal colonization using real-time nucleic acid amplification tests (NAATs) emerged as an alternative to antenatal culture screening methods.

Methods: We compared the performances of two loop-mediated isothermal amplification (LAMP) tests, the Ampliflash® GBS and the PlusLife® GBS tests, to standard culture for GBS detection in vaginal specimens from pregnant women. The study was conducted from April to July 2023 in a French hospital of the Paris area.

Results: A total of 303 samples were analyzed, including 85 culture-positive samples (28.1%). The Ampliflash® GBS test and the PlusLife® GBS tests gave a result for 100% and 96.3% tests, respectively. The performances of the tests were as follows: sensitivity 87.1% (95% confidence interval (CI) 78.3-92.6) and 98.7% (95% CI 93.0-99.8), specificity 99.1% (95% CI 96.7-99.8), and 91.9% (95% CI 87.3-95.0), respectively. False negative results of the Ampliflash® GBS test correlated with low-density GBS cultures. Time-to-results correlated with GBS culture density only for the PlusLife® GBS test (p < 0.001).

Conclusion: Both techniques provide excellent analytical performances with high sensitivity and specificity together with a short turnaround time and results available in 10 to 35 min. Their potential to further reduce the burden of GBS neonatal disease compared with antenatal culture screening needs to be assessed in future clinical studies.

References

Lamy M, Dramsi S, Billoet A, Reglier-Poupet H, Tazi A, Raymond J . Rapid detection of the "highly virulent" group B Streptococcus ST-17 clone. Microbes Infect. 2006; 8(7):1714-22. DOI: 10.1016/j.micinf.2006.02.008. View

Edwards R, Clark P, Duff P . Intrapartum antibiotic prophylaxis 2: positive predictive value of antenatal group B streptococci cultures and antibiotic susceptibility of clinical isolates. Obstet Gynecol. 2002; 100(3):540-4. DOI: 10.1016/s0029-7844(02)02097-5. View

Poncelet-Jasserand E, Forges F, Varlet M, Chauleur C, Seffert P, Siani C . Reduction of the use of antimicrobial drugs following the rapid detection of Streptococcus agalactiae in the vagina at delivery by real-time PCR assay. BJOG. 2013; 120(9):1098-108. DOI: 10.1111/1471-0528.12138. View

Couturier B, Weight T, Elmer H, Schlaberg R . Antepartum screening for group B Streptococcus by three FDA-cleared molecular tests and effect of shortened enrichment culture on molecular detection rates. J Clin Microbiol. 2014; 52(9):3429-32. PMC: 4313176. DOI: 10.1128/JCM.01081-14. View

Schrag S, Verani J . Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine. Vaccine. 2012; 31 Suppl 4:D20-6. PMC: 11843781. DOI: 10.1016/j.vaccine.2012.11.056. View

Shin J, Pride D . Comparison of Three Nucleic Acid Amplification Tests and Culture for Detection of Group B from Enrichment Broth. J Clin Microbiol. 2019; 57(6). PMC: 6535594. DOI: 10.1128/JCM.01958-18. View

Ke D, Menard C, Picard F, Boissinot M, Ouellette M, Roy P . Development of conventional and real-time PCR assays for the rapid detection of group B streptococci. Clin Chem. 2000; 46(3):324-31. View

El Helali N, Nguyen J, Ly A, Giovangrandi Y, Trinquart L . Diagnostic accuracy of a rapid real-time polymerase chain reaction assay for universal intrapartum group B streptococcus screening. Clin Infect Dis. 2009; 49(3):417-23. DOI: 10.1086/600303. View

Plainvert C, de Saint Salvy-Tabet Y, Dmytruk N, Frigo A, Poyart C, Tazi A . Group B Streptococcus (GBS) Invasive Infections in Women of Childbearing Age, France, 2012-2020: GBS CC-17 Hypervirulence in Intrapartum Infections. J Infect Dis. 2022; 226(3):541-545. DOI: 10.1093/infdis/jiac076. View

10.

El Aila N, Tency I, Claeys G, Saerens B, Cools P, Verstraelen H . Comparison of different sampling techniques and of different culture methods for detection of group B streptococcus carriage in pregnant women. BMC Infect Dis. 2010; 10:285. PMC: 2956727. DOI: 10.1186/1471-2334-10-285. View

11.

Nickmans S, Verhoye E, Boel A, Van Vaerenbergh K, De Beenhouwer H . Possible solution to the problem of nonhemolytic group B streptococcus on granada medium. J Clin Microbiol. 2011; 50(3):1132-3. PMC: 3295085. DOI: 10.1128/JCM.05372-11. View

12.

Nanduri S, Petit S, Smelser C, Apostol M, Alden N, Harrison L . Epidemiology of Invasive Early-Onset and Late-Onset Group B Streptococcal Disease in the United States, 2006 to 2015: Multistate Laboratory and Population-Based Surveillance. JAMA Pediatr. 2019; 173(3):224-233. PMC: 6439883. DOI: 10.1001/jamapediatrics.2018.4826. View

13.

Hoogkamp-Korstanje J, Gerards L, Cats B . Maternal carriage and neonatal acquisition of group B streptococci. J Infect Dis. 1982; 145(6):800-3. DOI: 10.1093/infdis/145.6.800. View

14.

Verani J, McGee L, Schrag S . Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010. MMWR Recomm Rep. 2010; 59(RR-10):1-36. View

15.

Seale A, Bianchi-Jassir F, Russell N, Kohli-Lynch M, Tann C, Hall J . Estimates of the Burden of Group B Streptococcal Disease Worldwide for Pregnant Women, Stillbirths, and Children. Clin Infect Dis. 2017; 65(suppl_2):S200-S219. PMC: 5849940. DOI: 10.1093/cid/cix664. View

16.

Puopolo K, Madoff L, Eichenwald E . Early-onset group B streptococcal disease in the era of maternal screening. Pediatrics. 2005; 115(5):1240-6. DOI: 10.1542/peds.2004-2275. View

17.

Carreras-Abad C, Ramkhelawon L, Heath P, Le Doare K . A Vaccine Against Group B : Recent Advances. Infect Drug Resist. 2020; 13:1263-1272. PMC: 7196769. DOI: 10.2147/IDR.S203454. View

18.

Plainvert C, El Alaoui F, Tazi A, Joubrel C, Anselem O, Ballon M . Intrapartum group B Streptococcus screening in the labor ward by Xpert® GBS real-time PCR. Eur J Clin Microbiol Infect Dis. 2017; 37(2):265-270. DOI: 10.1007/s10096-017-3125-2. View

19.

. [Antenatal prevention of early neonatal bacterial infection (September 2001)]. J Gynecol Obstet Biol Reprod (Paris). 2003; 32(1):68-74. View

20.

Xiao Z, Liu X, Kang X, Feng Y, Zheng L, Chen C . Rapid and accurate detection of SARS-CoV-2 using the RHAM technology. Sci Rep. 2023; 13(1):22798. PMC: 10739982. DOI: 10.1038/s41598-023-49733-7. View